Canada Gazette, Part I, Volume 153, Number 32: GOVERNMENT NOTICES

August 10, 2019

DEPARTMENT OF HEALTH

HAZARDOUS MATERIALS INFORMATION REVIEW ACT

Decisions, undertakings and orders on claims for exemption

Pursuant to paragraph 18(1)(a) of the Hazardous Materials Information Review Act, the Chief Screening Officer hereby gives notice of the decisions of the screening officer respecting each claim for exemption and the relevant safety data sheet (SDS) and (where applicable) the label listed below.

In accordance with section 20 of the Hazardous Materials Information Review Act, a claimant or any affected party, as defined, may appeal a decision or order of a screening officer. An affected party may also appeal an undertaking in respect of which a notice has been published in the Canada Gazette. To initiate the appeal process, a Statement of Appeal (Form 1) as prescribed by the Hazardous Materials Information Review Act Appeal Board Procedures Regulations must be completed and delivered, along with the fee prescribed by section 12 of the Hazardous Materials Information Review Regulations, within 45 days of the publication of this notice in the Canada Gazette, Part I, to the Chief Appeals Officer at the following address: Workplace Hazardous Materials Bureau, 269 Laurier Avenue West, 8th Floor, 4908B, Ottawa, Ontario K1A 0K9.

Véronique Lalonde
Chief Screening Officer

On February 11, 2015, the Hazardous Products Act (HPA) was amended, and the Controlled Products Regulations (CPR) and the Ingredient Disclosure List were repealed and replaced with the new Hazardous Products Regulations (HPR). The revised legislation (HPA/HPR) is referred to as WHMIS 2015.

All claims for exemption in this publication were filed and evaluated in accordance with the provisions of WHMIS 2015.

A Notice of Filing was published in Part I of the Canada Gazette and there were no written representations from affected parties with respect to any of the claims for exemption and related SDSs or labels mentioned below.

Each of the claims for exemption listed in the table below was found to be valid except for Registry Number (RN) 10243, which was found to be partially valid. The screening officer reached this decision after reviewing the information in support of the claim, having regard exclusively to the criteria found in section 3 of the Hazardous Materials Information Review Regulations.

RN Claimant Product Identifier Date of Decision
9135 MacDermid Enthone, Inc. ALUMON® AE-182 2019-03-28
9601 BYK USA Inc. NANOBYK-3610 2019-05-13
9720 CES Energy Solutions Sand Control Chemical 2019-05-22
9721 CES Energy Solutions EnerScav A 2019-05-10
9836 CES Energy Solutions EnerMul P-100 2019-06-10
9857 Nalco Canada ULC NALCO 62950 PLUS 2019-06-04
9863 Nalco Canada ULC NALCO® 64828 2019-04-26
10008 Innospec Fuel Specialties LLC OGI-6020 2019-05-10
10016 Nalco Canada ULC CLAR16730A 2019-06-20
10017 Nalco Canada ULC NALCO® EC6730A 2019-06-20
10027 Innospec Fuel Specialties LLC OGI-7680 2019-04-26
10045 Innospec Fuel Specialties LLC OGI-9010 2019-06-14
10160 Innospec Fuel Specialties LLC OGI-9993 2019-06-12
10243 Italmatch USA Corporation Polartech® EA 650 NS 2019-05-03
10245 Italmatch USA Corporation Polartech® EA 646 NS 2019-05-03
11824 Nalco Canada ULC NALCO® DVP4V005 2019-06-06

The claimant name on which the screening officer issued a decision for the following claims is different from the claimant name that was published in the Notice of Filing.

RN Notice of Filing Publication Date Original Claimant Name New Claimant Name
9135 2014-04-26 Enthone, Inc. MacDermid Enthone, Inc.
9720 2016-01-23 Canadian Energy Services CES Energy Solutions
9721 2016-01-23 Canadian Energy Services CES Energy Solutions
9836 2016-05-26 Canadian Energy Services CES Energy Solutions
10243 2016-11-05 Afton Chemical Corporation Italmatch USA Corporation
10245 2016-11-05 Afton Chemical Corporation Italmatch USA Corporation

The subject of the claim on which the screening officer issued a decision for the following claims is different from the subject of the claim that was published in the Notice of Filing.

RN Notice of Filing Publication Date Original Subject of the Claim Revised Subject of the Claim
9857 2016-07-30 C.i. and C. of one ingredient
C. of two ingredients		 C.i. of one ingredient
11824 2018-01-13 C.i. and C. of one ingredient
C. of two ingredients		 C.i. of one ingredient

Note: C.i. = chemical identity and C. = concentration

In all cases where the SDS or the label was determined not to be in compliance with the relevant legislation, pursuant to subsection 16.1(1) of the Hazardous Materials Information Review Act, the claimant was given 30 days to provide the screening officer with a signed undertaking accompanied by the SDS or the label amended as necessary.

Non-compliances that fall outside the scope of what is required to be published in the Canada Gazette are referred to as “administrative non-compliances.”

Please refer to Health Canada’s List of Active Claims for Exemption for a description of “administrative non-compliances” and their associated corrective measures.

CLAIMS FOR WHICH THE SCREENING OFFICER WAS SATISFIED THAT THE CLAIMANT HAD TAKEN THE MEASURES SET OUT IN THE UNDERTAKING

Pursuant to paragraph 18(1)(b) of the Hazardous Materials Information Review Act, the Chief Screening Officer hereby gives notice of information that has been disclosed on the relevant SDS or label in compliance with an undertaking and the date on which the notice referred to in subsection 16.1(3) of the Act was issued.

RN: 9135

Date of compliance undertaking: 2019-05-14

The claimant had been advised to correct administrative non-compliances in the SDS (or label) and had been further advised to amend the SDS (or label) as indicated below.

  1. Disclose the recommended use.
  2. Disclose the Canadian initial supplier identifier.
  3. Disclose the information elements concerning the additional hazard and precautionary statements.
  4. Disclose the applicable common names and synonyms for the ingredients “sodium hydroxide”, “caustic soda” and “ascarite”.
  5. Disclose the actual concentration of the ingredient “sodium hydroxide” or disclose a statement immediately following an HPR-prescribed concentration range to indicate that the actual concentration is withheld as trade secret for this ingredient.
  6. Disclose the product’s boiling range.
  7. Disclose conditions to avoid.
  8. Disclose “2,2,2-trichloroethanol (chlorinated solvent)”, “trichloroethylene (chlorinated solvent)”, “tetrachloroethylene (chlorinated solvent)”, “aluminum”, and “zinc” as incompatible materials.
  9. Disclose the calculated product oral ATE of 3 800 mg/kg (58.8% unknown).
  10. Correct the disclosure of misleading information regarding the LD50 (rat, oral) value for the confidential ingredient “sodium salt”.

RN: 9601

Date of compliance undertaking: 2019-07-08

The claimant had been advised to correct administrative non-compliances in the SDS (or label) and had been further advised to amend the SDS (or label) as indicated below.

  1. Disclose the Canadian initial supplier identifier.
  2. Disclose appropriate first aid measures in the case of “skin contact” and “eye contact”.
  3. Disclose the symptoms and effects, whether acute or delayed.
  4. Disclose the boiling range and the decomposition temperature.
  5. Correct the disclosure of misleading information regarding skin corrosion/irritation.
  6. Correct the disclosure of misleading information regarding hazardous ingredient properties in section 11, “Toxicological Information”.

RN: 9720

Date of compliance undertaking: 2019-06-26

The claimant had been advised to correct administrative non-compliances in the SDS (or label) and had been further advised to amend the SDS (or label) as indicated below.

  1. Disclose the recommended use.
  2. Disclose the Canadian initial supplier identifier.
  3. Disclose an adequate emergency telephone number.
  4. Disclose the additional health hazard classifications of “Reproductive Toxicity – Category 2” and “Specific Target Organ Toxicity – Single Exposure – Category 1 (oral, central nervous system, and kidney)”.
  5. Disclose the information elements concerning the additional hazard and precautionary statements.
  6. Disclose the percent of unknown toxicity of 0% for the calculated product oral ATE value.
  7. Disclose “Other hazards” on the SDS.
  8. Disclose the additional applicable common names and synonyms for the ingredient “ethylene glycol”.
  9. Disclose a first aid statement equivalent to “Remove contact lenses, if present and easy to do”.
  10. Disclose the symptoms and effects, whether acute or delayed.
  11. Disclose the immediate medical attention/special treatment needed for exposure to the product.
  12. Disclose first aid statements equivalent to “Obtain special instructions before use”, “Do not handle until all safety precautions have been read and understood”, and “Store locked up”.
  13. Disclose an ACGIH (TWA, STEL, C) of 10 mg/m3 (aerosol only) exposure limit for the ingredient “ethylene glycol”.
  14. Disclose an adequate product odour.
  15. Disclose the product’s viscosity.
  16. Disclose a sufficient description of the delayed and immediate effects, and chronic effects from short-term and long-term exposure.
  17. Correct the misleading information regarding “Reproductive Toxicity” in section 11 of the SDS.
  18. Disclose the calculated product oral ATE of 1 400 mg/kg (0% unknown), and dermal ATE of 3 000 mg/kg (5% unknown).
  19. Correct the disclosure of misleading information regarding the LD50 (rat, oral) value for the ingredient “ethylene glycol”.

RN: 9721

Date of compliance undertaking: 2019-06-05

The claimant had been advised to correct administrative non-compliances in the SDS (or label) and had been further advised to amend the SDS (or label) as indicated below.

  1. Remove CANUTEC’s emergency telephone number.
  2. Disclose the information elements concerning precautionary statements.
  3. Disclose “Other hazards” on the SDS.
  4. Disclose first aid statements equivalent to “IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing”.
  5. Disclose the symptoms and effects, whether acute or delayed.
  6. Disclose precautions for safe handling equivalent to “Store locked up”.
  7. Disclose the product’s evaporation rate.
  8. Disclose the product’s flammability.
  9. Disclose the product’s vapour pressure.
  10. Disclose the product’s viscosity.
  11. Disclose the calculated product oral ATE of 42 000 mg/kg (45–75% unknown).

RN: 9836

Date of compliance undertaking: 2019-06-28

The claimant had been advised to correct administrative non-compliances in the SDS (or label) and had been further advised to amend the SDS (or label) as indicated below.

  1. Remove CANUTEC’s emergency telephone number.
  2. Disclose “Other hazards” on the SDS.
  3. Disclose the percent of unknown toxicity of 40% for the calculated product inhalation ATE value.
  4. Disclose the information elements concerning the additional hazard and precautionary statements.
  5. Disclose the additional applicable common names and synonyms for the ingredient “distillates (petroleum), straight-run middle”.
  6. Disclose an adequate product odour.
  7. Disclose the product’s flammability.
  8. Disclose the product’s decomposition temperature.
  9. Disclose a sufficient description of the delayed and immediate effects, and chronic effects from short-term and long-term exposure.
  10. Specify which components of the hazard statements and precautionary statements apply.

RN: 9857

Date of compliance undertaking: 2019-07-09

The claimant had been advised to correct administrative non-compliances in the SDS (or label) and had been further advised to amend the SDS (or label) as indicated below.

  1. Disclose the appropriate restrictions on use.
  2. Remove CANUTEC’s emergency telephone number.
  3. Disclose the hazard classification of “Skin Corrosion — Category 1”.
  4. Disclose the information elements concerning the additional hazard and precautionary statements.
  5. Disclose the additional common names and synonyms for the ingredients “2-(2-butoxyethoxy)ethanol” and “lactic acid”.
  6. Disclose the applicable information for “the most important symptoms and effects, whether acute or delayed” under section 4, “First-aid measures”.
  7. Disclose a statement conveying the additional information on section 4 of the SDS.
  8. Disclose an adequate product odour.
  9. Disclose the product’s reactivity.
  10. Disclose the delayed and immediate effects, as well as the chronic effects from short-term and long-term exposure.
  11. Disclose the likely routes of exposure in section 11, “Toxicological Information”.
  12. Specify which components of the hazard and precautionary statements apply.

RN: 9863

Date of compliance undertaking: 2019-05-17

The claimant had been advised to correct administrative non-compliances in the SDS (or label) and had been further advised to amend the SDS (or label) as indicated below.

  1. Remove CANUTEC’s emergency telephone number.
  2. Disclose first aid statements equivalent to “IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing”.
  3. Disclose information on the precautions for firefighters.
  4. Disclose emergency procedures to follow in case of accidental release.
  5. Disclose the product’s reactivity.
  6. Disclose the delayed and immediate effects, as well as the chronic effects from short-term and long-term exposure.
  7. Disclose the likely route of exposure in section 11, “Toxicological Information”.
  8. Specify which components of the hazard and precautionary statements apply.

RN: 10008

Date of compliance undertaking: 2019-06-07

The claimant had been advised to correct administrative non-compliances in the SDS (or label) and had been further advised to amend the SDS (or label) as indicated below.

  1. Remove references to the Controlled Products Regulations from the SDS.
  2. Disclose the information elements concerning the additional hazard and precautionary statements.
  3. Disclose an adequate product odour.
  4. Disclose a boiling range and relative density.
  5. Disclose the likely routes of exposure in section 11, “Toxicological Information”.
  6. Disclose symptoms related to the product classification in section 11, “Toxicological Information”.
  7. Disclose a sufficient description of the delayed and immediate effects, and chronic effects from short-term and long-term exposure.
  8. Disclose the calculated product ATE value.

RN: 10016

Date of compliance undertaking: 2019-07-05

The claimant had been advised to correct administrative non-compliances in the SDS (or label) and had been further advised to amend the SDS (or label) as indicated below.

  1. Disclose an adequate emergency telephone number.
  2. Disclose the most important symptoms and effects, whether acute or delayed.
  3. Disclose the product’s reactivity.
  4. Disclose the delayed and immediate effects, and chronic effects from short-term and long-term exposure.

RN: 10017

Date of compliance undertaking: 2019-07-05

The claimant had been advised to correct administrative non-compliances in the SDS (or label) and had been further advised to amend the SDS (or label) as indicated below.

  1. Disclose an adequate emergency telephone number.
  2. Disclose the most important symptoms and effects, whether acute or delayed.
  3. Disclose the product’s reactivity.
  4. Disclose the delayed and immediate effects, and chronic effects from short-term and long-term exposure.

RN: 10027

Date of compliance undertaking: 2019-05-17

The claimant had been advised to correct administrative non-compliances in the SDS (or label) and had been further advised to amend the SDS (or label) as indicated below.

  1. Disclose the information elements concerning the additional hazard and precautionary statements.
  2. Disclose the product’s boiling range.
  3. Disclose the calculated product oral ATE of 4 700 mg/kg (85% unknown).
  4. Correct the disclosure of misleading information regarding the LD50 (rat, oral) value for the disclosed ingredient “isopropanol”.
  5. Disclose the likely route of exposure in section 11, “Toxicological Information”.
  6. Disclose the symptoms related to the physical, chemical and toxicological characteristics.
  7. Disclose the delayed and immediate effects, as well as the chronic effects from short-term and long-term exposure.

RN: 10045

Date of compliance undertaking: 2019-06-21

The claimant had been advised to correct administrative non-compliances in the SDS (or label) and had been further advised to amend the SDS (or label) as indicated below.

  1. Disclose the information elements concerning the precautionary statement.
  2. Correct the disclosure of misleading information regarding first aid measures.
  3. Correct the misleading information with respect to personal protective equipment in section 6, “Accidental release measures”.
  4. Disclose a sufficient description of the delayed and immediate effects, and chronic effects from short-term and long-term exposure.
  5. Disclose the symptoms related to the physical, chemical and toxicological characteristics.
  6. Disclose the likely routes of exposure in section 11, “Toxicological Information”.
  7. Disclose the correct reference and term with respect to the HPR and the SDS.

RN: 10160

Date of compliance undertaking: 2019-06-27

The claimant had been advised to correct administrative non-compliances in the SDS (or label) and had been further advised to amend the SDS (or label) as indicated below.

  1. Disclose the Canadian initial supplier identifier.
  2. Disclose the applicable information for “Incompatibilities” under section 7, “Handling and storage”.
  3. Disclose an adequate product odour.
  4. Disclose a sufficient description of the delayed and immediate effects, and chronic effects from short-term and long-term exposure.
  5. Disclose the likely routes of exposure in section 11, “Toxicological Information”.
  6. Disclose the symptoms related to the physical, chemical and toxicological characteristics.
  7. Disclose the correct reference and term with respect to the HPR and the SDS.

RN: 10245

Date of compliance undertaking: 2019-06-10

The claimant had been advised to correct administrative non-compliances in the SDS (or label) and had been further advised to amend the SDS (or label) as indicated below.

  1. Disclose the Canadian initial supplier identifier.
  2. Disclose the information elements concerning the additional hazard and precautionary statements.
  3. Disclose a sufficient description of the symptoms and effects, whether acute or delayed.
  4. Disclose the appropriate precautions for safe handling.
  5. Disclose an adequate product odour.
  6. Disclose the product’s boiling range.
  7. Correct the disclosure of misleading information regarding conditions to avoid.

RN: 11824

Date of compliance undertaking: 2019-07-09

The claimant had been advised to correct administrative non-compliances in the SDS (or label) and had been further advised to amend the SDS (or label) as indicated below.

  1. Remove CANUTEC’s emergency telephone number.
  2. Disclose the information elements concerning the additional hazard and precautionary statements.
  3. Disclose the applicable information for “the most important symptoms and effects” under section 4, “First-aid measures”.
  4. Disclose information on the precautions for firefighters.
  5. Disclose statements that convey the applicable information on section 7 of the SDS.
  6. Disclose an adequate product odour.
  7. Disclose the product’s reactivity.
  8. Disclose the delayed and immediate effects, as well as the chronic effects from short-term and long-term exposure.
  9. Specify which components of the hazard and precautionary statements apply.

CLAIMS FOR WHICH THE SCREENING OFFICER ISSUED THE DECISION THAT THE CLAIM FOR EXEMPTION WAS EITHER PARTIALLY VALID OR INVALID

In the case of the following claims, the screening officer issued the decision that the claim for exemption was partially valid.

Pursuant to section 18 of the Hazardous Materials Information Review Act, the Chief Screening Officer hereby gives notice of information that the screening officer ordered to be disclosed on an SDS or a label pursuant to subsection 16(1) and information that has been disclosed on the relevant SDS or label in compliance with an undertaking, and the dates on which the orders and notices referred to in subsection 16.1(3) of the Act were issued.

RN: 10243

Date of compliance undertaking: 2019-06-10

The claimant had been advised to correct administrative non-compliances in the SDS (or label) and had been further advised to amend the SDS (or label) as indicated below.

  1. Disclose the Canadian initial supplier identifier.
  2. Disclose the chemical identity and remove the link between the ingredient “sodium petroleum sulfonates” and the registry number on the SDS.
  3. Disclose the information elements concerning the additional hazard and precautionary statements.
  4. Disclose a sufficient description of the symptoms and effects, whether acute or delayed.
  5. Disclose the appropriate precautions for safe handling.
  6. Disclose an adequate product odour.
  7. Disclose the product’s boiling range.

DEPARTMENT OF INDUSTRY

OFFICE OF THE REGISTRAR GENERAL

Appointments
Name and position Order in Council
Immigration and Refugee Board  
Full-time members  
Bulmer, Mary Krista 2019-1039
Liberman, Ron David 2019-1031
Seyan, Ravninder 2019-1038
Singh, Inderpreet Kaur 2019-1037
Lawless, Daren 2019-1023
Natural Sciences and Engineering Research Council  
Member  
Mirasty, Russell B. 2019-1093
Lieutenant Governor of the Province of Saskatchewan  
Smith, Charles Randall 2019-0355
Royal Canadian Mounted Police External Review Committee  
Chairperson  

August 1, 2019

Diane Bélanger
Official Documents Registrar

DEPARTMENT OF INDUSTRY

OFFICE OF THE REGISTRAR GENERAL

Senator called

Her Excellency the Governor General has been pleased to summon to the Senate of Canada, by letters patent under the Great Seal of Canada bearing the date of July 22, 2019:

August 1, 2019

Diane Bélanger
Official Documents Registrar

DEPARTMENT OF PUBLIC SAFETY AND EMERGENCY PREPAREDNESS

CRIMINAL CODE

Designation as fingerprint examiner

Pursuant to subsection 667(5) of the Criminal Code, I hereby designate the following persons of the Delta Police Department as fingerprint examiners:

Ottawa, July 26, 2019

Ellen Burack
Assistant Deputy Minister
Community Safety and Countering Crime Branch

DEPARTMENT OF PUBLIC SAFETY AND EMERGENCY PREPAREDNESS

CRIMINAL CODE

Designation as fingerprint examiner

Pursuant to subsection 667(5) of the Criminal Code, I hereby designate the following person of the Winnipeg Police Service as a fingerprint examiner:

Ottawa, July 26, 2019

Ellen Burack
Assistant Deputy Minister
Community Safety and Countering Crime Branch

OFFICE OF THE SUPERINTENDENT OF FINANCIAL INSTITUTIONS

BANK ACT

Peoples Bank of Canada — Letters patent of incorporation

Notice is hereby given of the issuance, pursuant to section 22 of the Bank Act, of letters patent incorporating Peoples Bank of Canada and, in French, Banque Peoples du Canada, effective July 4, 2019.

July 10, 2019

Jeremy Rudin
Superintendent of Financial Institutions

PRIVY COUNCIL OFFICE

Appointment opportunities

We know that our country is stronger — and our government more effective — when decision-makers reflect Canada’s diversity. The Government of Canada has implemented an appointment process that is transparent and merit-based, strives for gender parity, and ensures that Indigenous peoples and minority groups are properly represented in positions of leadership. We continue to search for Canadians who reflect the values that we all embrace: inclusion, honesty, fiscal prudence, and generosity of spirit. Together, we will build a government as diverse as Canada.

We are equally committed to providing a healthy workplace that supports one’s dignity, self-esteem and the ability to work to one’s full potential. With this in mind, all appointees will be expected to take steps to promote and maintain a healthy, respectful and harassment-free work environment.

The Government of Canada is currently seeking applications from diverse and talented Canadians from across the country who are interested in the following positions.

Current opportunities

The following opportunities for appointments to Governor in Council positions are currently open for applications. Every opportunity is open for a minimum of two weeks from the date of posting on the Governor in Council Appointments website.

Position Organization Closing date
President and Chief Executive Officer Canada Lands Company Limited  
Board Member (Anticipatory) Canadian Accessibility Standards Development Organization  
Chairperson (Anticipatory) Canadian Accessibility Standards Development Organization  
Chief Executive Officer (Anticipatory) Canadian Accessibility Standards Development Organization  
Vice-Chairperson (Anticipatory) Canadian Accessibility Standards Development Organization  
Chairperson Canadian Dairy Commission  
Chairperson, Vice-Chairperson and Director Canadian Energy Regulator  
Chief Executive Officer Canadian Energy Regulator  
Lead Commissioner, Deputy Lead Commissioner and Commissioner Canadian Energy Regulator  
Pay Equity Commissioner Canadian Human Rights Commission  
President (Chief Executive Officer) Canadian Tourism Commission  
Chairperson Farm Credit Canada  
Member (appointment to roster) International Trade and International Investment Dispute Settlement Bodies  
Auditor General of Canada Office of the Auditor General  
Chief Accessibility Officer (Anticipatory) Office of the Chief Accessibility Officer  
Chief Executive Officer Parks Canada  
Commissioner Public Service Commission  
Member and Alternate Member Renewable Resources Board (Gwich’in)  
Member and Alternate Member Renewable Resources Board (Sahtu)